Caesar J. Belbel
Overview
Caesar J. Belbel received an average of $963K in total compensation, including $260K in salary, at ZIOPHARM Oncology from 2011 to 2013.
Source: SEC filing on April 30, 2014.
Related executives
We found ten more executives who work or worked at ZIOPHARM Oncology.
Kevin Boyle
ZIOPHARM Oncology
Chief Executive Officer
Melinda Lackey
ZIOPHARM Oncology
SVP, Legal & Administration
Drew Deniger
ZIOPHARM Oncology
VP, Research and Development
Jonathan Lewis
ZIOPHARM Oncology
Chief Executive Officer
Hagop Youssoufian
ZIOPHARM Oncology
Chief Medical Officer
Jason Amello
ZIOPHARM Oncology
Chief Financial Officer
Kevin Lafond
ZIOPHARM Oncology
Chief Accounting Officer
Richard Bagley
ZIOPHARM Oncology